A case of Vogt-Koyanagi-Harada disease associated with malignant lymphoma

被引:12
作者
Hashida, N
Kanayama, S
Kawasaki, A
Ogawa, K
机构
[1] Osaka Univ, Sch Med, Dept Ophthalmol, Suita, Osaka 5650871, Japan
[2] Toyonaka City Hosp, Dept Ophthalmol, Osaka, Japan
关键词
malignant lymphoma; soluble interleukin-2 receptor; Vogt-Koyanagi-Harada disease;
D O I
10.1007/s10384-004-0177-5
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background: Vogt-Koyanagi-Harada disease (VKH), an inflammatory ocular disorder characterized by bilateral granulomatous panuveitis and a variety of extraocular manifestations, has been reported to be associated with various immune disorders but has not been linked to malignant lymphoma (ML). Case: We present here a case of VKH associated with a recurrence of ML. Observations: A 69-year-old man who initially had ML presented with a history of sudden bilateral visual acuity loss. Funduscopy showed papilloedema and serous retinal detachment in both eyes, and a diagnosis of VKH was reached soon thereafter. Chest X-ray and an abdominal computed tomography scan indicated the metastatic focus of the ML. A recurrence was suspected because the ML-associated soluble interleukin-2 receptor (sIL-2R) in the serum was highly elevated. Treatment successfully resolved both the ML and the VKH. The inflammatory activities of VKH and ML were found to correlate with the serum levels of sIL-2R. Conclusions: This case suggests an association between sIL-2R levels and disease activity in VKH and ML, and provides additional evidence that VKH can be induced by immune disorders caused by high sIL-2R levels in ML. (c) Japanese Ophthalmological Society 2005.
引用
收藏
页码:253 / 256
页数:4
相关论文
共 10 条
[1]  
Alpsoy Erkan, 1998, Journal of Dermatology (Tokyo), V25, P513
[2]  
ERNST BB, 1991, OPHTHALMOLOGY, V98, P1272
[3]   Cytokine production and helper T cell subsets in Vogt-Koyanagi-Harada's disease [J].
Imai, YM ;
Sugita, M ;
Nakamura, S ;
Toriyama, S ;
Ohno, S .
CURRENT EYE RESEARCH, 2001, 22 (04) :312-318
[4]  
KOGISO M, 1992, JPN J OPHTHALMOL, V36, P37
[5]   VOGT-KOYANAGI-HARADA SYNDROME [J].
MOORTHY, RS ;
INOMATA, H ;
RAO, NA .
SURVEY OF OPHTHALMOLOGY, 1995, 39 (04) :265-292
[6]   SOLUBLE INTERLEUKIN-2 RECEPTORS IN RETINAL VASCULITIS [J].
MURRAY, PI ;
YOUNG, DW .
CURRENT EYE RESEARCH, 1992, 11 :193-195
[7]   Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease [J].
Norose, K ;
Yano, A .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1996, 80 (11) :1002-1008
[8]  
Ohno Hitoshi, 2002, Rinsho Ketsueki, V43, P170
[9]  
SYMONS JA, 1988, J IMMUNOL, V141, P2612
[10]  
Uchio E, 1999, CLIN EXP RHEUMATOL, V17, P179